Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1, Open Label Dose-Finding Study of Intranasal Insulin in Healthy Participants

NCT05062785 is registered in ClinicalTrials.gov with Robert Silbergleit as lead sponsor.

NCT NCT05062785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05062785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1, Open Label Dose-Finding Study of Intranasal Insulin in Healthy Participants
Lead sponsor
Robert Silbergleit
Phase
Phase 1
Overall status
Completed
Start date
October 4, 2021
Completion date
April 25, 2022
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, out-of-hospital cardiac arrest